LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
University of Georgia
Headquarters:
Athens, GA, United States
Website:
http://www.uga.edu
Year Founded:
1785
Status:
Non-biopharma
Biopharma related deals can be found by searching the organization's name in the
Deals
Module.
BioCentury
|
Sep 7, 2023
Product Development
ARPA-H supports a new side of mRNA research
Emory-led project gains ARPA-H backing to control immune cell function
Read More
BioCentury
|
Jan 9, 2020
Financial News
Jan. 8 Financial Quick Takes: Intra-Cellular raises $295M; plus venture rounds for nference, Eyevensys, Transcenta, Airway, Progentec
Read More
BioCentury
|
Dec 5, 2019
Emerging Company Profile
VaxNewMo: bioconjugating antibacterial vaccines
VaxNewMo’s platform could yield new, less costly glycoconjugate vaccines
Read More
BioCentury
|
May 2, 2019
Emerging Company Profile
SAB: Human polyclonal antibodies on the hoof
SAB uses cows, goats to overcome limitations of generating polyclonal antibodies
Read More
BioCentury
|
Jan 3, 2019
Distillery Therapeutics
Infectious disease
Read More
BioCentury
|
Jan 4, 2018
Translation in Brief
ArunA’s exosome entrance
Why ArunA decided to develop exosome therapeutics for stroke
Read More
BioCentury
|
Sep 22, 2017
Politics, Policy & Law
Conferred immunity in IPR
Why Allergan’s purchase of sovereign immunity from an Indian tribe could end IPR
Read More
BioCentury
|
Aug 14, 2014
Distillery Therapeutics
Indication: Cancer
Read More
BioCentury
|
Mar 24, 2014
Strategy
The price of success
How payers hope to gain price leverage over new HCV drugs like Gilead's Sovaldi
Read More
BioCentury
|
Mar 17, 2014
Emerging Company Profile
Partikula: Mitochondrial delivery
Partikula delivering chemotherapeutics into mitochondria of cancer cells
Read More
Items per page:
10
1 - 10 of 51